Contact· self-published, not guessed
Experience
- UCBPartner, UCB Venturescurrent2019 — presentGreater Boston
- M VenturesPrincipalcurrent2016 — presentGreater Boston
- EMD Serono, Inc.Associate, MS Ventures2014 — 2016Greater Boston
- EMD - Affiliates of Merck KGaA, Darmstadt, GermanyBusiness Development Manager, New Business Franchises2013 — 2014Greater Boston
- Merck SeronoAnalyst, Business Development and Global Licensing2010 — 2012Geneva
- Sanofi PasteurGlobal Medical Affairs2010Lyon
- Master Research ProjectLeiden Amsterdam Centre for Drug Research2008 — 2009Leiden, The Netherlands
- ROEMMERSIntern quality control2008Buenos Aires, Argentina
Skills & more
Strategy1Pharmaceutical Industry1Venture Capital3Business Development and Licensing1
From Alicia's professional profile.
Deals · 1
Switch TherapeuticsBoard seat
via UCB Ventures · filed Nov 2022 · $36M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at UCB Ventures
Frequently asked questions
- Who is Alicia Irurzun-Lafitte?
- Partner at UCB Ventures
- Where does Alicia Irurzun-Lafitte work?
- Alicia Irurzun-Lafitte is Partner at UCB Ventures.
- What boards does Alicia Irurzun-Lafitte sit on?
- Alicia Irurzun-Lafitte holds tracked board seats at Switch Therapeutics.
- Where did Alicia Irurzun-Lafitte go to school?
- Alicia Irurzun-Lafitte studied at Babson F.W. Olin Graduate School of Business (Master of Business Administration - MBA); Leiden University (Msc, Bio Pharmaceutical Sciences and Science-based Business).
Same school
Also attended Babson F.W. Olin Graduate School of Business116
Jeff DoranInvestor at Spark CapitalPierre-Eric LeiboviciInvestor at DaphniKevin MunnellyInvestor at Third Rock VenturesBrian DixonManaging Partner at Kapor CapitalMurat BicerGeneral Partner at CRV (Charles River Ventures)Jeremy CurleySenior Director at JMI Equity
+ 110 more
Also attended Leiden University105
Andrea van ElsasInvestor at Third Rock VenturesJoost HollemanInvestor at Prime VenturesFredric PetitPartner, Head of Materials & Packaging at Emerald Technology Ventures AgJeroen PlinkVenture Partner at LegalTechThijs SchaapInvestment manager at NoaberRoel BulthuisInvestor at Syncona
+ 99 more
Shared employers
Also worked at UCB23
Ben PerryInvestor at MedicxiStephen RapeckiInvestor at MedicxiMary PattonScientific Advisory Board at InnoCom Bio EquitiesMiguel ForteAdvisor at Delin VenturesJohn LeonardExecutives in Residence at GENERAL INCEPTIONSam GrayManaging Partner at Apposite Capital
+ 17 more
Also worked at EMD Serono, Inc.8
Chris RobinsonInvestor at Third Rock VenturesRoel BulthuisInvestor at SynconaYvonne YamanakaPartner at venBio PartnersParis PanayiotopoulosSenior Managing Director at Blackstone Life SciencesDaguang WangManaging Director at Yonjin Venture LLCMaria V Lopez-BresnahanInvestment Advisory Committee at 3CC | Third Culture Capital
+ 2 more
Also worked at EMD - Affiliates of Merck KGaA, Darmstadt, Germany15
Petra MeyerInvestor at Golden SeedsVincent RulandEntrepreneur-in-Residence at Versant VenturesWhitney PengFund Administrator at Lever VCTherese LiechtensteinPartner at 4BIO CapitalStella PaffenholzSenior Associate at Atlas VentureMathias FalcenbergVenture Partner at V-Bio Ventures
+ 9 more
Also worked at Merck Serono15
Giovanni MariggiInvestor at MedicxiRoel BulthuisInvestor at SynconaMathias FalcenbergVenture Partner at V-Bio VenturesParis PanayiotopoulosSenior Managing Director at Blackstone Life SciencesFrederic WohlwendManaging Partner at Forestay CapitalGeorg Vo BeiskeVenture Partner | MSc at HealthCap
+ 9 more